USA Cancer Care Developments Supporting the Chemotherapy Induced...

agregó una foto Health

2026-06-04 12:59:50 -

USA Cancer Care Developments Supporting the Chemotherapy Induced Peripheral Neuropathy Market

Chemotherapy-Induced Peripheral Neuropathy (CIPN) is one of the most common and challenging side effects associated with cancer therapy, affecting patients' quality of life and treatment outcomes. According to market estimates, the chemotherapy induced peripheral neuropathy market is expected to grow from US$ 1.01 billion in 2025 to US$ 1.67 billion by 2034, registering a CAGR of 5.71% during...

0 Commentarios 0 Acciones 102 Views 0 Vista previa